Document is current

Article History

First Online: 18 May 2024

Acknowledgements

: EUDF board: Chantal Mathieu (EASD), Stefano Del Prato (EFSD), Anne-Marie Felton (FEND), Niti Pall (IDF Europe), Carine de Beaufort (ISPAD), Carmen Hurtado del Pozo (JDRF), Xavier Cos (PCDE) and Jean-François Gautier (SFD).

: The activities of EUDF are financially supported by EASD, EFSD, FEND, IDF Europe, ISPAD, JDRF, PCDE, SFD, EFPIA and MedTech Europe.

: SDP consulted for Abbott, Amarin Corporation, Applied Therapeutics, AstraZeneca, Eli Lilly and Company, Eva Pharma, Menarini International, Novo Nordisk, Sanofi and Sun Pharmaceuticals, and received funding for these consulting services; received grant support from AstraZeneca and Boehringer Ingelheim; and received speaker fees from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Laboratori Guidotti, Menarini International, MSD, Novartis Pharmaceuticals, Novo Nordisk and Sanofi. CM serves or has served on the advisory panel for Novo Nordisk, Sanofi, Eli Lilly and Company, Novartis, Boehringer Ingelheim, Roche, Medtronic, Imcyse, Insulet, Biomea Fusion and Vertex. Financial compensation for these activities has been received by KU Leuven; KU Leuven has received research support for CM from Medtronic, Imcyse, Novo Nordisk, Sanofi and ActoBio Therapeutics; CM serves or has served on the speakers bureau for Novo Nordisk, Sanofi, Eli Lilly and Company, Medtronic and Boehringer Ingelheim. Financial compensation for these activities has been received by KU Leuven. CM is president of EASD. All external support of EASD is to be found on .

Free to read: This content has been made available to all.